Werewolf Therapeutics, Inc. (NASDAQ:HOWL) filed a Form 8-K with the Securities and Exchange Commission on February 06, 2026, disclosing a material event.
Werewolf Therapeutics, Inc.'s stock currently trades at $0.61 with a market capitalization of $53.4M. The Healthcare company's stock moved following the disclosure.